ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Protective Effect of Fucoidan Against Tacrolimus-Induced Nephrotoxicity in LLC-PK1 Cells

H. J. Jang

Surgery, University of Ulsan, Gangneung Asan Hospital, Gangneung, Korea, Republic of

Meeting: 2020 American Transplant Congress

Abstract number: C-374

Keywords: Apoptosis, FK506, Nephrotoxicity

Session Information

Session Name: Poster Session C: Immunosuppression Preclinical Studies

Session Type: Poster Session

Date: Saturday, May 30, 2020

Session Time: 3:15pm-4:00pm

 Presentation Time: 3:30pm-4:00pm

Location: Virtual

*Purpose: Tacrolimus (FK506) is an immunosuppressant agent that is frequently used to prevent rejection of solid organs upon transplant. However, nephrotoxicity due to apoptosis and inflammatory response mediated by FK506 limit its usefulness. Fucoidan (FUC) is an antioxidant and anti-inflammatory sulfated polysaccharide compound from brown seawood. In the present study, the protective effect of FUC against FK506-induced damage in LLC-PK1 pig kidney epithelial cells was investigated.

*Methods: LLC-PK1 cells were exposed to FK506 with FUC and cell viability was measured. Western blotting and RT-PCR analyses evaluated protein or gene expression of HO-1, Bcl-2, Bax, caspase-3/9, kidney injury molecule-1 (KIM-1), and Toll-like receptor-2 (TLR-2) expression were assessed. The number of apoptotic cells was measured using an annexin V/PI staining with flow cytometry.

*Results: Reduction in cell viability by 50mM FK506 was ameliorated significantly by cotreatment with FUC. KIM-1, TLR-2, BAX and cleaved caspase-3/9, increased markedly in LLC-PK1 cells treated with FK506 and significantly decreased after cotreatment with FUC. HO-1 and Bcl-2 significantly increased in LLC-PK1 cells treated with FK506 after cotreatment with FUC. Moreover, flow cytometry assay showed that apoptotic cell death was increased by FK506 treatment, whereas it was decreased after cotreatment with FUC.

*Conclusions: These results collectively provide therapeutic evidence that FUC ameliorates the FK506-induced renal damage via antioxidant effect and inhibiting apoptosis and inflammation.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Jang HJ. Protective Effect of Fucoidan Against Tacrolimus-Induced Nephrotoxicity in LLC-PK1 Cells [abstract]. Am J Transplant. 2020; 20 (suppl 3). https://atcmeetingabstracts.com/abstract/protective-effect-of-fucoidan-against-tacrolimus-induced-nephrotoxicity-in-llc-pk1-cells/. Accessed May 11, 2025.

« Back to 2020 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences